MVMD’s patented Quicksol™️ solubility technology enhances new and existing compounds in the macrocyclic drug class that focus on improving livestock and aquatic species disease prevention and nutrition.
MVMD works with our partners to improve the health and productivity of animal and fish farming operations to support improved global human food supply chains.
While MVMD’s current commercialization is focused on animal husbandry disease prevention, the solubility technology applied to the Ivermectin drug is the only form in the world that uses strictly excipients that are currently approved by the US Food and Drug Administration (FDA), making it a potential candidate for human injection. MVMD has plans to further evaluate the human applications in future R&D phases.
MVMD offers organic Agrarius products which help farmers dramatically increase crop yields with less reliance on fertilizer and pesticides, reducing greenhouse gas emissions – which helps reduce their environmental impact.
MVMD’s Quicksome™ technology enhances existing and new nutraceutical products to help individuals achieve their wellness goals.
MVMD’s Quicksol™️ technology helps to enhance existing and new compounds that can improve livestock and aquatic species disease prevention and nutrition.